Inventor
LAU JOHNSON YIU-NAM
US32 patents
⚠️ This page may combine multiple inventors who share the name “LAU JOHNSON YIU-NAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERSITECH LTD
7 patentsUS11441198B2Sep 13, 2022
Compositions and methods for providing a prognosis for influenza infection
VERSITECH LTD0 citations60
US11357773B2Jun 14, 2022
Methods and compositions for enhancing immune response to vaccination
VERSITECH LTD0 citations57
US12144856B2Nov 19, 2024
Compositions and methods for enhancing immune response to vaccination and improving vaccine production
VERSITECH LTD0 citations56
US12213955B2Feb 4, 2025
Compositions and methods for broad-spectrum antiviral therapy
VERSITECH LTD0 citations55
US11826425B2Nov 28, 2023
Compositions and methods for treatment of enterovirus infection
VERSITECH LTD0 citations55
US11123421B2Sep 21, 2021
Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery
VERSITECH LTD0 citations48
US12090029B2Sep 17, 2024
Devices and methods for enhancing immunogenicity to intradermal vaccination
VERSITECH LTD0 citations44
ATHENEX HK INNOVATIVE LTD
6 patentsUS10849893B2Dec 1, 2020
Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer
ATHENEX HK INNOVATIVE LTD2 citations67
US10835511B2Nov 17, 2020
Oral taxane compositions and methods
ATHENEX HK INNOVATIVE LTD3 citations66
US11752139B2Sep 12, 2023
Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancer
ATHENEX HK INNOVATIVE LTD0 citations57
US11389442B2Jul 19, 2022
Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer
ATHENEX HK INNOVATIVE LTD1 citations57
US11963942B2Apr 23, 2024
Oral taxane compositions and methods
ATHENEX HK INNOVATIVE LTD0 citations56
US11752156B2Sep 12, 2023
Compositions and methods for treating hyperproliferative skin disorders
ATHENEX HK INNOVATIVE LTD0 citations50
NANSHA BIOLOGICS HONG KONG LTD
4 patentsUS11931417B2Mar 19, 2024
Methods of preparing a pegylated human IL-11 composition
NANSHA BIOLOGICS HONG KONG LTD0 citations58
US10946103B2Mar 16, 2021
Methods of treatment using a branched amino terminal pegylated Il-11 composition
NANSHA BIOLOGICS HONG KONG LTD0 citations58
US10881739B2Jan 5, 2021
Interleukin-11 PEGylation reaction intermediate composition
NANSHA BIOLOGICS HONG KONG LTD0 citations58
US10335492B2Jul 2, 2019
Increasing serum half-life of human IL-11 variants by N-terminal branched PEGylation
NANSHA BIOLOGICS HONG KONG LTD0 citations47
ATHENEX INC
3 patentsUS10617693B2Apr 14, 2020
Methods of treating and/or preventing actinic keratosis
ATHENEX INC6 citations79
US11497750B2Nov 15, 2022
Methods of treating and/or preventing actinic keratosis
ATHENEX INC2 citations68
US11739089B2Aug 29, 2023
Acetamido-phenyltetrazole derivatives and methods of using the same
ATHENEX INC2 citations54